TY - JOUR
T1 - Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients
AU - Wang, Feiqian
AU - Jiang, Hongli
AU - Shi, Kehui
AU - Ren, Yi
AU - Zhang, Pan
AU - Cheng, Shaoli
PY - 2012/11
Y1 - 2012/11
N2 - Aim: To investigate whether gut bacteria translocation occurs in end-stage renal disease patients and contributes to microinflammation in end-stage renal disease (ESRD). Methods: The subjects were divided into two groups: nondialysed ESRD patients (n = 30) and healthy controls (n = 10). Blood samples from all participants were subjected to bacterial 16S ribosomal DNA amplification and DNA pyrosequencing to determine the presence of bacteria, and the alteration of gut microbiomes were examined with the same methods. High-sensitive C-reactive protein and interleukin-6 were detected. Plasma D-lactate was tested for gut permeability. Results: Bacterial DNAs were detected in the blood of 20% (6/30) of the ESRD patients. All the observed genera in blood (Klebsiella spp, Proteus spp, Escherichia spp, Enterobacter spp, and Pseudomonas spp) were overgrown in the guts of the ESRD patients. Plasma D-lactate, High-sensitive C-reactive protein, and interleukin-6 levels were significantly higher in patients with bacterial DNA than those without. The control group showed the same results as that of patients without bacterial DNA. Conclusion: Bacterial translocation occurs in ESRD patients and is associated with microinflammation in end stage renal disease. Wang et al. evaluated the bacterial translocation in the intestinal tract in non-dialysed ESRD patients and its contribution to micoinflammation in the patient population.
AB - Aim: To investigate whether gut bacteria translocation occurs in end-stage renal disease patients and contributes to microinflammation in end-stage renal disease (ESRD). Methods: The subjects were divided into two groups: nondialysed ESRD patients (n = 30) and healthy controls (n = 10). Blood samples from all participants were subjected to bacterial 16S ribosomal DNA amplification and DNA pyrosequencing to determine the presence of bacteria, and the alteration of gut microbiomes were examined with the same methods. High-sensitive C-reactive protein and interleukin-6 were detected. Plasma D-lactate was tested for gut permeability. Results: Bacterial DNAs were detected in the blood of 20% (6/30) of the ESRD patients. All the observed genera in blood (Klebsiella spp, Proteus spp, Escherichia spp, Enterobacter spp, and Pseudomonas spp) were overgrown in the guts of the ESRD patients. Plasma D-lactate, High-sensitive C-reactive protein, and interleukin-6 levels were significantly higher in patients with bacterial DNA than those without. The control group showed the same results as that of patients without bacterial DNA. Conclusion: Bacterial translocation occurs in ESRD patients and is associated with microinflammation in end stage renal disease. Wang et al. evaluated the bacterial translocation in the intestinal tract in non-dialysed ESRD patients and its contribution to micoinflammation in the patient population.
KW - bacteria translocation
KW - end-stage renal disease
KW - gut
KW - microbiome dysbiosis
KW - microinflammation
UR - https://www.scopus.com/pages/publications/84868153873
U2 - 10.1111/j.1440-1797.2012.01647.x
DO - 10.1111/j.1440-1797.2012.01647.x
M3 - 文章
C2 - 22817644
AN - SCOPUS:84868153873
SN - 1320-5358
VL - 17
SP - 733
EP - 738
JO - Nephrology
JF - Nephrology
IS - 8
ER -